{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:10:33Z","timestamp":1759579833347},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T00:00:00Z","timestamp":1382054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s11255-013-0583-z","type":"journal-article","created":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T04:50:34Z","timestamp":1381985434000},"page":"757-760","source":"Crossref","is-referenced-by-count":5,"title":["Prostate cancer risk after anti-androgen treatment for priapism"],"prefix":"10.1007","volume":"46","author":[{"given":"Tabitha","family":"Goetz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur L.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,18]]},"reference":[{"issue":"6","key":"583_CR1","doi-asserted-by":"crossref","first-page":"12620","DOI":"10.3390\/ijms140612620","volume":"14","author":"M Rigau","year":"2013","unstructured":"Rigau M, Olivan M, Garcia M, Sequeiros T, Montes M, Col\u00e1s E, Llaurad\u00f3 M, Planas J, Torres I, Morote J, Cooper C, Revent\u00f3s J, Clark J, Doll A (2013) The present and future of prostate cancer urine biomarkers. Int J Mol Sci 14(6):12620\u201312649","journal-title":"Int J Mol Sci"},{"issue":"3","key":"583_CR2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/MOU.0b013e3283384047","volume":"20","author":"S Loeb","year":"2010","unstructured":"Loeb S, Catalona WJ (2010) Prostate-specific antigen screening: pro. Curr Opin Urol 20(3):185\u2013188","journal-title":"Curr Opin Urol"},{"issue":"1","key":"583_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.canlet.2006.12.029","volume":"249","author":"MA Reynolds","year":"2007","unstructured":"Reynolds MA, Kastury K, Groskopf J, Schalken JA, Rittenhouse H (2007) Molecular markers for prostate cancer. Cancer Lett 249(1):5\u201313","journal-title":"Cancer Lett"},{"issue":"7","key":"583_CR4","first-page":"527","volume":"52","author":"K Noguchi","year":"2006","unstructured":"Noguchi K, Suzuki K, Teranishi J, Kondo K, Kishida T, Saito K, Uemura H, Kubota Y (2006) Recovery of serum prostate specific antigen value after interruption of antiandrogen therapy with allylestrenol for benign prostatic hyperplasia. Hinyokika Kiyo 52(7):527\u2013530","journal-title":"Hinyokika Kiyo"},{"issue":"2","key":"583_CR5","first-page":"84","volume":"79","author":"V Magri","year":"2007","unstructured":"Magri V, Trinchieri A, Montanari E, Del Nero A, Mangiarotti B, Zirpoli P, de Eguileor M, Marras E, Ceriani I, Vral A, Perletti G (2007) Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection. Arch Ital Urol Androl 79(2):84\u201392","journal-title":"Arch Ital Urol Androl"},{"issue":"1","key":"583_CR6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0090-4295(01)01492-3","volume":"59","author":"P Dahm","year":"2002","unstructured":"Dahm P, Rao DS, Donatucci CF (2002) Antiandrogens in the treatment of priapism. Urology 59(1):138","journal-title":"Urology"},{"issue":"5","key":"583_CR7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.urology.2005.11.045","volume":"67","author":"AL Burnett","year":"2006","unstructured":"Burnett AL, Bivalacqua TJ, Champion HC, Musicki B (2006) Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology 67(5):1043\u20131048","journal-title":"Urology"},{"issue":"2","key":"583_CR8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","volume":"157","author":"VA Moyer","year":"2012","unstructured":"Moyer VA, US Preventive Services Task Force (2012) Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 157(2):120\u2013134","journal-title":"Ann Intern Med"},{"issue":"9","key":"583_CR9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.amjmed.2010.05.011","volume":"123","author":"N Parekh","year":"2010","unstructured":"Parekh N, Lin Y, Dipaola RS, Marcella S, Lu-Yao G (2010) Obesity and prostate cancer detection: insights from three national surveys. Am J Med 123(9):829\u2013835","journal-title":"Am J Med"},{"issue":"1","key":"583_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003495-199346010-00010","volume":"46","author":"DH Peters","year":"1993","unstructured":"Peters DH, Sorkin EM (1993) Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia. Drugs 46(1):177\u2013208","journal-title":"Drugs"},{"issue":"2","key":"583_CR11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.maturitas.2013.03.006","volume":"75","author":"P Posadzki","year":"2013","unstructured":"Posadzki P, Lee MS, Onakpoya I, Lee HW, Ko BS, Ernst E (2013) Dietary supplements and prostate cancer: a systematic review of double-blind, placebo-controlled randomized clinical trials. Maturitas 75(2):125\u2013130","journal-title":"Maturitas"},{"issue":"8","key":"583_CR12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/pros.21122","volume":"70","author":"AM Algotar","year":"2010","unstructured":"Algotar AM, Thompson PA, Ranger-Moore J, Stratton MS, Hsu CH, Ahmann FR, Nagle RB, Stratton SP (2010) Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity. Prostate 70(8):883\u2013888","journal-title":"Prostate"},{"issue":"9","key":"583_CR13","first-page":"999","volume":"31","author":"YH Lin","year":"2010","unstructured":"Lin YH, Jiang YG, Li MC, Luo Y, Wang JS (2010) Effects of prostate manipulation on serum total and free prostate specific antigen, and free-to-total prostate specific antigen ratio. Saudi Med J 31(9):999\u20131004","journal-title":"Saudi Med J"},{"issue":"Suppl 6","key":"583_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1464-410X.2012.11215.x","volume":"109","author":"R Schr\u00f6der","year":"2012","unstructured":"Schr\u00f6der R, Crawford ED, Axcrona K, Payne H, Keane TE (2012) Androgen deprivation therapy: past, present and future. BJU Int 109(Suppl 6):1\u201312","journal-title":"BJU Int"},{"issue":"1 Pt 2","key":"583_CR15","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1743-6109.2009.01625.x","volume":"7","author":"GA Broderick","year":"2010","unstructured":"Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R (2010) Priapism: pathogenesis, epidemiology, and management. J Sex Med 7(1 Pt 2):476\u2013500","journal-title":"J Sex Med"},{"issue":"1","key":"583_CR16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/aja.2011.114","volume":"14","author":"HR Levey","year":"2012","unstructured":"Levey HR, Kutlu O, Bivalacqua TJ (2012) Medical management of ischemic stuttering priapism: a contemporary review of the literature. Asian J Androl 14(1):156\u2013163","journal-title":"Asian J Androl"},{"issue":"4","key":"583_CR17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11934-012-0258-9","volume":"13","author":"BF Morrison","year":"2012","unstructured":"Morrison BF, Burnett AL (2012) Stuttering priapism: insights into pathogenesis and management. Curr Urol Rep 13(4):268\u2013276","journal-title":"Curr Urol Rep"},{"key":"583_CR18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/j.1939-4640.1997.tb01967.x","volume":"18","author":"AR Granata","year":"1997","unstructured":"Granata AR, Rochira V, Lerchl A et al (1997) Relationship between sleep-related erections and testosterone levels in men. J Androl 18:522\u2013527","journal-title":"J Androl"},{"issue":"1","key":"583_CR19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1743-6109.2012.02707.x","volume":"10","author":"AL Burnett","year":"2013","unstructured":"Burnett AL, Sharlip ID (2013) Standard operating procedures for priapism. J Sex Med 10(1):180\u2013194","journal-title":"J Sex Med"},{"issue":"2","key":"583_CR20","first-page":"CD00709121","volume":"16","author":"TJ Wilt","year":"2008","unstructured":"Wilt TJ, MacDonald R, Hagerty K, Schellhammer P, Kramer BS (2008) Five-alpha-reductase Inhibitors for prostate cancer prevention. Cochrane Database Syst Rev 16(2):CD00709121","journal-title":"Cochrane Database Syst Rev"},{"key":"583_CR21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/pros.22638","volume":"73","author":"TJ Murtola","year":"2013","unstructured":"Murtola TJ, Kujala PM, Tammela TLJ (2013) High-grade prostate cancer and biochemical recurrence after radical prostatectomy among men using 5\u03b1-reductase inhibitors and alpha-blockers. Prostate 73:923\u2013931","journal-title":"Prostate"},{"issue":"5","key":"583_CR22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200023050-00003","volume":"23","author":"R Paul","year":"2000","unstructured":"Paul R, Breul J (2000) Antiandrogen withdrawal syndrome associated with prostate cancer therapies: incidence and clinical significance. Drug Saf 23(5):381\u2013390","journal-title":"Drug Saf"},{"issue":"2","key":"583_CR23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.juro.2012.08.198","volume":"189","author":"G Lagoda","year":"2013","unstructured":"Lagoda G, Sezen SF, Cabrini MR, Musicki B, Burnett AL (2013) Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis. J Urol 189(2):762\u2013768","journal-title":"J Urol"},{"issue":"7","key":"583_CR24","doi-asserted-by":"crossref","first-page":"e68028","DOI":"10.1371\/journal.pone.0068028","volume":"8","author":"TJ Bivalacqua","year":"2013","unstructured":"Bivalacqua TJ, Musicki B, Hsu LL, Berkowitz DE, Champion HC, Burnett AL (2013) Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative\/nitrosative stress. PLoS One 8(7):e68028","journal-title":"PLoS One"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-013-0583-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-013-0583-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-013-0583-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T18:45:52Z","timestamp":1716057952000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-013-0583-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,18]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["583"],"URL":"https:\/\/doi.org\/10.1007\/s11255-013-0583-z","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,18]]}}}